Senior Clinical Research Associate
Pubblicato il 11-09-2026 - Ire in Milano
Senior Clinical Research Associate
ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster.
As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers.
As a Senior CRA at ICON Plc, you will oversee and manage clinical trial activities to ensure they are conducted according to protocol, regulatory requirements, and industry standards.
What You Will Do:
You will lead on clinical trial monitoring tasks requiring technical depth, with a focus on quality and continuous improvement.
Key responsibilities include:
- Monitoring clinical trial sites to ensure adherence to study protocols, regulatory requirements, and Good Clinical Practice (GCP) standards.
- Conducting site visits to assess site performance, resolve issues, and provide support to ensure successful trial execution.
- Collaborating with cross-functional teams to ensure timely and accurate data collection and reporting.
- Providing training and guidance to site staff and other CRAs to maintain high standards of clinical trial conduct.
- Building and maintaining effective relationships with site personnel and stakeholders to facilitate smooth trial operations.
Your Profile:
You will have a strong foundation in clinical trial monitoring, with the experience to work independently and guide others.
Required qualifications and experience:
- Bachelor's degree in a relevant scientific discipline or healthcare-related field
- Extensive experience as a Clinical Research Associate, with a strong understanding of clinical trial processes and regulatory requirements.
- Proven ability to manage multiple sites and projects simultaneously, with strong organizational and problem-solving skills.
- Expertise in monitoring practices, data integrity, and site management, with proficiency in relevant clinical trial